CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

about

Tumor evolution and chemoresistance in ovarian cancer Phenotypic Basis for Matrix Stiffness-Dependent Chemoresistance of Breast Cancer Cells to Doxorubicin

P2860

Q58733743-47E137B1-0FEF-46CE-8DD3-DCC72A54BE45 Q58762922-B7C9478B-4F5A-49CD-8487-C4715A195821

P2860

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

Item

http://www.wikidata.org/entity/Q52642950

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

@en

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

@nl

type

Item

label

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

@en

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

@nl

prefLabel

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

@en

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

@nl

P1476

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

@en

P2093

Bo-Wen Liu

http://www.w3.org/2001/XMLSchema#string

Fang Zhang

http://www.w3.org/2001/XMLSchema#string

Jian-Ying Cui

http://www.w3.org/2001/XMLSchema#string

Liang Chen

http://www.w3.org/2001/XMLSchema#string

Linlin Wang

http://www.w3.org/2001/XMLSchema#string

Yue-Ting Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Epithelial-mesenchymal transitions in development and disease

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration

IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway

The EMT (epithelial-mesenchymal-transition)-related protein expression indicates the metastatic status and prognosis in patients with ovarian cancer.

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer.

Primary malignant lymphoma of the uterus and broad ligament: a case report and review of literature.

Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition

Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling.

P304

2081-2090

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2018.6311

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29565447

http://www.w3.org/2001/XMLSchema#string

P932

5928760

http://www.w3.org/2001/XMLSchema#string

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

about

P2860

P2860

CAFs enhance paclitaxel resistance by inducing EMT through the IL‑6/JAK2/STAT3 pathway.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932